Volume growth masks pricing pressure; recovery claims need Q2 validation

Occupancy 75.7% (+314 bps YoY); but ARR grew only 2% despite occupancy tailwind

Management confirms Q1 was deliberate volume strategy due to West Asia conflict; claims Q2 onwards balanced approach

Management fees ₹45.4 Cr, up 21% YoY; validated by 16% network revenue growth

EBITDA margin 43.8% vs 44.8% prior year (-100 bps); GST impact 3.1%, renovation 2.25%, SAR provision cited; implies ~2.2% from other factors

Prior call implied balanced occupancy-ARR growth. Q1 shows tactical pivot to volume (retail mid-30s of mix) accepting lower ARR (+2% vs occupancy +314 bps). Management claims temporary for Q1 only; recovery expected Q2.

Prior call: 'significant pricing power for Aurika Mumbai in FY27 given occupancies stabilized.' Q1 result: occupancy softness in Mumbai/Gurgaon due to 2,000-room supply. Now calling Q1 'aberration' and deferring guidance to Q2.

Management repeatedly stated Q1 impacted by West Asia conflict (lower inbound, corporate travel cuts). July/August already showing 'significant' improvement. Implies near-term trough, not structural demand issue.

Reaffirmed 300 rooms in Q1, similar in Q2, rest in H1 as high-value renovations. H2 shifts to refurbishment (lower cost). By FY28, revert to normal ~1% of revenue.

Targeting ₹60 Cr EBITDA from Keys (implies ₹115-120 Cr revenue). Portfolio 2/3 renovated; Pimpri/Whitefield showing strong results; targeting Red Fox-level ARRs (₹4,500 achieved). Next year expect full performance as occupancies reach Lemon Tree average.

Yes, tactical pivot in Q1 to retail (lower net ARR due to commissions) after West Asia conflict reduced corporate/inbound demand. Temporary measure; reverting to balanced approach in Q2 onwards. Corporate segment tightened travel, so volume strategy was necessary.

Q1 was aberration due to West Asia impact. Mumbai absorbing 2,000-room supply overhang; temporary mismatch. Q2 expected better. Focusing on ARR repricing of Aurika now that occupancies stabilized. Market will catch up.

Two-pronged: Aurika/Lemon Tree Premier in Tier 1 demand-dense markets; Keys in Tier 2/3 for penetration. Asset-light signings up sharply (2023: 2,000, 2024: 3,500, 2025: 5,000 rooms). 30-month lag before openings translate to fee income.

GST 3.1% (new impact), renovation 2.25% (down from 5.8% prior), SAR provision. Incremental spend ~₹6 Cr. FY27 expecting better; FY28 expecting 50%+ net EBITDA margin as renovation drops to 1% and ARR recovers.

Flywheel effect: signings 3+ years out translate to openings. 1,300 rooms added Q1-YoY; portfolio stabilizing. Same-store growth 9%-10%, new hotels adding incrementally. Expected 'enormous' fee income growth as 5,000-room FY25 cohort opens in FY29.

Promised to provide detailed case studies (Lemon Tree Delhi, Hyderabad investments ₹85 Cr). Performance improvement visible but lag due to ongoing renovations. Will publish in next investor presentation for transparency.

Not in up cycle; India occupancy mid-60s (up cycle is 70%+). Demand-dense markets have moats even during cycles. Capital deployment at right locations (top 6-7 cities, outbound India leisure), not timing market bottom.

Following customer base: 32 million Indians travel overseas, 12 million+ to UAE/Nepal/Thailand/Maldives. Loyalty program (2.5M members) repeats internationally. Monetizing existing customers. No specific % target given.

Incorrect; capex staged over 3-3.5 years. Land 20%-30% upfront, then 15% Y1, 25%-30% Y2, 30%-35% Y3. Use 1:1 debt-equity; covers first 2 years. Debt not frontloaded. Debt-to-EBITDA hovering around 2x is target.

Efficiency gains + revenue management + direct channel growth hard to quantify separately. MVP 1/2 rolled out in owned portfolio. Plan to offer managed portfolio once satisfied. New contracts link tech upgrades to brand standards.

Q1 impacted by West Asia conflict; July/August showing recovery. Corporate/inbound demand expected to normalize. No specific % number given.

Q1 43.8%; expects recovery in H2. Renovation capex tapering, ARR recovery, and seasonal strength (H2 higher margins) to drive improvement.

Renovation spend drops 1% of revenue; GST dilution reduces progressively; operating leverage from fee income acceleration. Management states 'no reason why not 50%'.

Assumes fee income doubles and below-the-line expenses (talent, tech) as % of revenue reduce to 20%-25%. Requires sustained growth in signed rooms and fee quality.

High-value renovations (₹10-12 Lakhs/key) mostly done; balance is lower-cost refurbishment (₹2.5-3 Lakhs/key). Declining from 2.25% of revenue to ~1% by FY28.

Mix of operating assets and greenfield/brownfield. Warburg ₹960 Cr + internal cash. Phased deployment (20%-30% upfront for land, 15%-30% Y1/Y2, 30%-35% Y3).

Q1 impacted by West Asia conflict reducing inbound and corporate travel. Management claims July/August recovery, but lacks proof. If recovery delayed, revenue/margin guidance misses.

ARR +2% despite occupancy +314 bps signals willingness to sacrifice pricing for volume. If corporate/higher-yield segments remain soft, mix shift to retail (lower margin) may persist.

50% FY28 margin target requires: (1) renovation completion, (2) ARR +5-6% rebound, (3) GST input credit optimization, (4) cost control. Any miss cascades to lower profitability.

₹2,500-3,000 Cr capex over 3-3.5 years with Warburg ₹960 Cr. If acquisitions underperform, IRRs miss 15%+ target. Debt-to-EBITDA could spike if cash generation lags.

Demerger expected H2 CY 2027 (late Q2-Q3 2027). SEBI approval, shareholder/creditor vote, NCLT, GST approval required. Delays possible. Post-demerger Lemon Tree (41%) may trade at premium/discount based on asset-light model acceptance.

Analyst (Vikram Shah, Vikram Securities) flagged quality deterioration at Lemon Tree Premier Delhi and Rishikesh. Management disputed (claims 4.6/5 score post-renovation). Potential brand perception risk if quality issues widespread.